Abstract
No public abstract is available from the verified source records.
Craig W Berridge, Amy FT Arnsten
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Dissociating executive functions of the prefrontal cortex
10.1098/rstb.1996.0131 · 1996
Networks related to the orbital and medial prefrontal cortex; a substrate for emotional behavior?
10.1016/s0079-6123(08)61885-3 · 1996
Neurobiology of attention regulation and its disorders
2002
Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection
10.1016/s1053-8119(03)00275-1 · 2003
From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses
10.1016/j.biopsych.2010.07.024 · 2011
Executive “brake failure” following deactivation of human frontal lobe
2006
Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia
10.1176/appi.ajp.158.7.1105 · 2001
Subgenual prefrontal cortex abnormalities in mood disorders
10.1038/386824a0 · 1997
Neurobiological circuits regulating attention, cognitive control, motivation, and emotion: disruptions in neurodevelopmental psychiatric disorders
10.1016/j.jaac.2012.01.008 · 2012
Development of cortical asymmetry in typically developing children and its disruption in attention-deficit/hyperactivity disorder
10.1001/archgenpsychiatry.2009.103 · 2009
Cortical thinning of the attention and executive function networks in adults with attention-deficit/hyperactivity disorder
10.1093/cercor/bhl047 · 2007
Frontostriatal connectivity and its role in cognitive control in parent-child dyads with adhd
10.1176/appi.ajp.2007.06101754 · 2007
The neuropsychopharmacology of fronto-executive function: monoaminergic modulation
10.1146/annurev.neuro.051508.135535 · 2009
Cellular basis of working memory
10.1016/0896-6273(95)90304-6 · 1995
Alpha2a-adrenoceptors strengthen working memory networks by inhibiting camp-hcn channel signaling in prefrontal cortex
10.1016/j.cell.2007.03.015 · 2007
Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses
10.1016/j.neuron.2012.08.038 · 2012
Dynamic network connectivity: a new form of neuroplasticity
10.1016/j.tics.2010.05.003 · 2010
Delayed-response deficit induced by local injection of the alpha 2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys
10.1016/s0163-1047(05)80034-2 · 1994
Locomotor hyperactivity induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys
10.1016/j.biopsych.2004.11.004 · 2005
Selective deficit in no-go performance induced by blockade of prefrontal cortical alpha 2-adrenoceptors in monkeys
2003
Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory
10.1038/nn1846 · 2007
Dopamine D(1) receptor-mediated enhancement of nmda receptor trafficking requires rapid pkc-dependent synaptic insertion in the prefrontal neurons
10.1111/j.1471-4159.2010.06720.x · 2010
Stress signalling pathways that impair prefrontal cortex structure and function
10.1038/nrn2648 · 2009
Cognition-enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness
10.1016/j.biopsych.2008.04.037 · 2008
Unresolved referenced work
2009
Attention deficit hyperactivity disorder
2012
The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder
10.1001/archpsyc.1996.01830050084013 · 1996
Catecholamine receptors on locus coeruleus neurons: pharmacological characterization
10.1016/0014-2999(77)90312-0 · 1977
Comparison of the binding activities of some drugs on alpha 2a, alpha 2b and alpha 2c-adrenoceptors and non-adrenergic imidazoline sites in the guinea pig
10.1111/j.1600-0773.1995.tb00161.x · 1995
Noradrenergic modulation of wakefulness/arousal
10.1016/j.smrv.2011.12.003 · 2012
Guanfacine is an effective countermeasure for hypobaric hypoxia-induced cognitive decline
10.1016/j.neuroscience.2013.09.023 · 2013
Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors
10.1074/jbc.m113.458901 · 2013
Guanfacine for the treatment of cognitive disorders: a century of discoveries at yale
2012
The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology
10.1016/s0065-3101(24)00289-5 · 1992
Pharmacological treatment of attention deficit disorder, residual type in adults
1985
Clinical effects of stimulant medication in adhd
2001
Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study
10.1097/01.jcp.0000106223.36344.df · 2004
Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder
10.1016/j.biopsych.2010.06.023 · 2011
A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for adhd and its treatment
10.1093/brain/awt263 · 2013
Hippocampus norepinephrine, caudate dopamine and serotonin, and behavioral responses to the stereoisomers of amphetamine and methamphetamine
10.1523/jneurosci.15-02-01308.1995 · 1995
Methylphenidate improves prefrontal cortical cognitive function through alpha2 adrenoceptor and dopamine d1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder
10.1186/1744-9081-1-2 · doi-reference
Psychostimulants act within the prefrontal cortex to improve cognitive function
10.1016/j.biopsych.2011.12.002 · doi-reference
Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine d1 receptors
10.1016/j.jaac.2010.06.015 · doi-reference
A Selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: potential relevance to attention deficit hyperactivity disorder
10.1016/j.neuropharm.2012.07.005 · doi-reference
Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: Evidence that dopamine is taken up in vivo by noradrenergic terminals
10.1111/j.1471-4159.1990.tb04599.x · doi-reference
Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder
10.1016/s0893-133x(02)00346-9 · doi-reference
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines
10.1523/jneurosci.22-02-00389.2002 · doi-reference
Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence
10.1016/s0021-9258(17)37256-3 · doi-reference
Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters
10.1016/s0021-9258(17)33961-3 · doi-reference
Neurocircuitry underlying the preferential sensitivity of prefrontal catecholamines to low-dose psychostimulants
10.1038/npp.2013.6 · doi-reference
Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature
10.1542/peds.111.1.179 · doi-reference
Methylphenidate enhances noradrenergic transmission and suppresses mid- and long-latency sensory responses in the primary somatosensory cortex of awake rats
10.1152/jn.01310.2005 · doi-reference
Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine
10.1523/jneurosci.22-16-07264.2002 · doi-reference
Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function
10.1016/j.biopsych.2006.04.022 · doi-reference